Erytech Pharma S.A. - American Depositary Shares (ERYP) SEC filings
ERYP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ERYP overview →
3 measured ERYP SEC filing events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 6-K PHAXIAM Therapeutics For: Jan 18 | SEC filing · Form 6-K | — | — | |
| Form 6-K PHAXIAM Therapeutics For: Nov 14 | SEC filing · Form 6-K | — | — | |
| Form 6-K PHAXIAM Therapeutics For: Oct 24 | SEC filing · Form 6-K | — | — |
Keep exploring
More ERYP: earnings → · analyst actions → · ERYP overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Vanda Pharmaceuticals Inc. (VNDA) | 363 | -0.22% | 44% |
| Rezolute, Inc. - (NV) (RZLT) | 362 | -0.23% | 44% |
| AQUINOX PHARMACEUTICALS (AQXP) | 357 | 0.00% | 46% |
| Hologic, Inc. (HOLX) | 357 | -0.00% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.